CPSF6

Cleavage and polyadenylation specificity factor subunit 6 · Q16630 · CPSF6 on Sugi Atlas →

0 patent compounds predicted against CPSF6, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to CPSF6 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Reverse Transcriptase Inhibitors in AGS PHASE2COMPLETED
PhII 5-Azacytidine Plus Valproic Acid and Eventually Atra in Intermediate II and High Risk MDS PHASE2COMPLETED
Clinical Study of EBV-LMP1 Targeted DNAzyme to Treat Nasopharyngeal Carcinoma PHASE1/PHASE2COMPLETED
Application of mRNA Immunotherapy Technology in Epstein-Barr Virus-related Refractory Malignant Tumors PHASE1ACTIVE_NOT_RECRUITING
MiRNA223 and HMGB1 as Apredictos for Drug Resistant Epilepsy nanUNKNOWN
Role of SF3B1 Mutation in Assessment of Acute and Chronic Lymphatic Leukemia nanNOT_YET_RECRUITING
Association of SNPs in Long Intergenic Noncoding RNA 00511 (LINC00511) With Breast Cancer Among the Egyptian Population nanCOMPLETED
Becker Muscular Dystrophy - A Natural History Study to Predict Efficacy of Exon Skipping nanUNKNOWN
MicroRNA-1 (miRNA-1) and MicroRNA-133a (miRNA-133a) Levels After Acute Exercise in Ultimate Frisbee Athletes nanUNKNOWN
Prevalence of a Non-Expressing 11B Mutation in Aka Peoples of the Central African Republic nanCOMPLETED
Patient's Derived Organoids for Drug Screening in Glioblastoma nanNOT_YET_RECRUITING
LINC00511/miR-185-3p Axis and miR-301a-3p Markers for Breast Cancer Diagnosis nanCOMPLETED
miR-155 Expression in Episodic and Chronic Migraine nanUNKNOWN
Study to Explore Natural Daily Variation and Impact of Stress in HIV Levels nanCOMPLETED
Biomarkers in Patients With Diffuse Large B-Cell Lymphoma Treated With Combination Chemotherapy With or Without Rituximab nanCOMPLETED
Circulating Markers for Ischemic Heart Disease nanRECRUITING
Efficacy and Safety Study of EGCG/Tocotrienol in 18 Patients With Splicing-mutation-mediated Cystic Fibrosis (CF) nanCOMPLETED
Aberrant Splicings Due to Microsatellite Instability in Colorectal Cancer : Physiopathological and Clinical Impact nanUNKNOWN
RNA Sequencing in the Framingham Heart Study Third Generation Cohort Exam 2 nanCOMPLETED
Impact of Mutations in Aminoacyl tRNA Synthetases on Protein Translation and Cellular Stress nanWITHDRAWN
Na+ Channel mRNA Regulation in Heart Failure nanCOMPLETED
Family Resilience Initiative Research Program nanUNKNOWN
Study of Constitutional Platelet Disease nanUNKNOWN
Diagnosis of RSTS: Identification of the Acetylation Profiles as Epigenetic Markers for Assessing Causality of CREBBP and EP300 Variants. nanUNKNOWN
Genetic Factors Affecting the Severity of Beta Thalassemia nanCOMPLETED
Apoptosis Markers in Aggressive Periodontitis nanCOMPLETED
DNA Methylation and Perioperative Pain Treatment nanCOMPLETED
Germline Alterations of Tumor Susceptibility Genes in New York Cancer Patients nanACTIVE_NOT_RECRUITING
Role of Specific microRNAs in Cluster Headache nanRECRUITING
Selinexor (Nexpovio®) (SVd) in Patients With Relapsed or Refractory Multiple Myeloma nanACTIVE_NOT_RECRUITING

Related proteins — ESM-2 sequence neighbours (a CPSF6 binder may also engage these)

ProteinNameSimilarity
Q6NVF9 1.000 Q6NVF9 →
Q0P5D2 1.000 Q0P5D2 →
Q5NVH8 1.000 Q5NVH8 →
Q5ZL34 1.000 Q5ZL34 →
Q6NWC6 1.000 Q6NWC6 →
Q6DDW4 1.000 Q6DDW4 →
Q8BTV2 0.994 Q8BTV2 →
Q5XI29 0.992 Q5XI29 →
Q9VSH4 0.990 Q9VSH4 →
CPSF7 Cleavage and polyadenylation specificity factor subunit 7 0.989 landscape →
Q8VIJ6 0.989 Q8VIJ6 →
SFPQ Splicing factor, proline- and glutamine-rich 0.988 landscape →
Q63627 0.986 Q63627 →
Q0DA50 0.986 Q0DA50 →
A9LNK9 0.986 A9LNK9 →
Q2T9I5 0.985 Q2T9I5 →
Q9VIV2 0.985 Q9VIV2 →
Q1LZD9 0.984 Q1LZD9 →
Q9LV14 0.984 Q9LV14 →
Q923D5 0.984 Q923D5 →
Q5PQQ2 0.984 Q5PQQ2 →
Q9Y2W2 0.984 Q9Y2W2 →
Q8TAP9 0.983 Q8TAP9 →
PSPC1 Paraspeckle component 1 0.983 landscape →
O95104 0.983 O95104 →
A0A8M2 0.983 A0A8M2 →
Q767K9 0.982 Q767K9 →
PPP1R10 Serine/threonine-protein phosphatase 1 regulatory subunit 10 0.982 landscape →
Q0V898 0.982 Q0V898 →
Q4KLH4 0.982 Q4KLH4 →